The future of affordable cancer immunotherapy
N Schaft, J Dörrie, G Schuler… - Frontiers in …, 2023 - frontiersin.org
The treatment of cancer was revolutionized within the last two decades by utilizing the
mechanism of the immune system against malignant tissue in so-called cancer …
mechanism of the immune system against malignant tissue in so-called cancer …
The interplay between medical plants and gut microbiota in cancer
S Caserta, C Genovese, N Cicero, V Toscano… - Nutrients, 2023 - mdpi.com
The gut microbiota is a dynamic community of bacteria distributed in the gastroenteric tract
and changes in response to diseases, diet, use of antibiotics and probiotics, hygiene status …
and changes in response to diseases, diet, use of antibiotics and probiotics, hygiene status …
[HTML][HTML] Longitudinal analysis of the gut microbiota during anti-PD-1 therapy reveals stable microbial features of response in melanoma patients
ADG Macandog, C Catozzi, M Capone, A Nabinejad… - Cell host & …, 2024 - cell.com
Immune checkpoint inhibitors (ICIs) improve outcomes in advanced melanoma, but many
patients are refractory or experience relapse. The gut microbiota modulates antitumor …
patients are refractory or experience relapse. The gut microbiota modulates antitumor …
Gut–lung axis: role of the gut microbiota in non-small cell lung cancer immunotherapy
H Zhang, Z Xu - Frontiers in Oncology, 2023 - frontiersin.org
Immunotherapy for non-small cell lung cancer (NSCLC) has advanced considerably over
the past two decades. In particular, immune checkpoint inhibitors are widely used for treating …
the past two decades. In particular, immune checkpoint inhibitors are widely used for treating …
[HTML][HTML] Insights into the Relationship Between the Gut Microbiome and Immune Checkpoint Inhibitors in Solid Tumors
S Ciernikova, A Sevcikova, M Novisedlakova, M Mego - Cancers, 2024 - mdpi.com
Immunotherapy with immune checkpoint inhibitors represents a revolutionary approach to
the treatment of solid tumors, including malignant melanoma, lung cancer, and …
the treatment of solid tumors, including malignant melanoma, lung cancer, and …
Correlation of distribution characteristics and dynamic changes of gut microbiota with the efficacy of immunotherapy in EGFR-mutated non-small cell lung cancer
WC Luo, SQ Mei, ZJ Huang, ZH Chen… - Journal of Translational …, 2024 - Springer
Background The effects of gut microbiota and metabolites on the responses to immune
checkpoint inhibitors (ICIs) in advanced epidermal growth factor receptor (EGFR) wild-type …
checkpoint inhibitors (ICIs) in advanced epidermal growth factor receptor (EGFR) wild-type …
[PDF][PDF] The future of affordable cancer immunotherapy
B Schuler-Thurner, H Sallam, S Klein, G Eisenberg… - 2023 - opus4.kobv.de
Immunotherapy has changed the cancer treatment scenario and revolutionized tumor
immunology. Immunotherapy treatments, such as adoptive T-cell therapy (ACT) or the use of …
immunology. Immunotherapy treatments, such as adoptive T-cell therapy (ACT) or the use of …